2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
2.12 Financial assets (continued)
(d) Subsequent measurement – Impairment (continued)
Assets carried at amortised cost (continued)
The amount of the loss is measured as the difference between the asset’s carrying amount and the present value
of estimated future cash flows (excluding future credit losses that have not been incurred) discounted at the
financial asset’s original effective interest rate. The carrying amount of the asset is reduced and the amount of
the loss is recognised in profit or loss. If ‘loans and receivables’ or a ‘held-to-maturity investment’ has a variable
interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined
under the contract. As a practical expedient, the Group may measure impairment on the basis of an instrument’s
fair value using an observable market price.
If, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively
to an event occurring after the impairment was recognised (such as an improvement in the debtor’s credit rating),
the reversal of the previously recognised impairment loss is recognised in profit or loss.
When an asset is uncollectible, it is written off against the related allowance account. Such assets are written
off after all the necessary procedures have been completed and the amount of the loss has been determined.
Assets classified as available-for-sale
The Group assesses at the end of the reporting period whether there is objective evidence that a financial asset
or a group of financial assets is impaired.
For debt securities, the Group uses criteria and measurement of impairment loss applicable for ‘assets carried at
amortised cost’ above. If, in a subsequent period, the fair value of a debt instrument classified as available for sale
increases and the increase can be objectively related to an event occurring after the impairment loss was
recognised in profit or loss, the impairment loss is reversed through the profit or loss.
In the case of equity securities classified as available-for-sale, in addition to the criteria for ‘assets carried at
amortised cost’ above, a significant or prolonged decline in the fair value of the security below its cost is also
considered as an indicator that the assets are impaired. If any such evidence exists for available-for-sale financial
assets, the cumulative loss that had been recognised directly in equity is removed from equity and recognised in
profit or loss. The amount of cumulative loss reclassified to profit or loss is the difference between the acquisition
cost and the current fair value, less any impairment loss on that financial asset previously recognised in profit or
loss. Impairment losses recognised in profit or loss on equity instruments classified as available-for-sale are not
reversed through profit or loss in subsequent periods.
247
KPJ Healthcare Berhad
Annual Report
2015
NOTES TO THE
FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2015 (CONTINUED)
